Stocks · News reference
U.S. stocks slightly up, Dow Jones gains 0.1%. Health care shares jump 2.8%, ON Semiconductor down 20%. Oil down 4%, gold up 1.2%, eurozone and Asian markets closed lower.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
On August 24, 2026, the United States District Court for the Southern District of California (the "Court") preliminarily approved the settlement ("Settlement") of the stockholder derivative action
Filed: 2026-09-11 AccNo: 0001193125-26-389400 Size: 604 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Deutsche Bank analyst David Hoang maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Buy and raises the price target from $37 to $38.
Morgan Stanley analyst Jeffrey Hung maintains ACADIA Pharmaceuticals (NASDAQ:ACAD) with a Equal-Weight and raises the price target from $27 to $28.
Filed: 2026-09-14 AccNo: 0000006845-26-000091 Size: 583 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Core & Main (CNM) reported quarterly earnings of $0.94 per share, beating consensus estimates of $0.93, with revenues of $2.15 billion slightly exceeding expectations. However, the stock has underperformed the market by 15.2% year-to-date and carries a Zacks Rank #3 (Hold) rating. Meanwhile, Apogee Enterprises (APOG) is expected to report a significant 39.8% year-over-year earnings decline in its upcoming quarterly results.